The Japan Science and Technology Agency is promoting the development of immunoregulatory drugs for autoimmune diseases such as rheumatoid arthritis promoted by Osaka University as a new project of the university-initiated new industry creation program that promotes the research and development and business development of university-launched venture companies in an integrated manner. The case was adopted.The research will start as soon as the contract is completed.
According to the Japan Science and Technology Agency, projects adopted by companies other than Osaka University are: ▽ Establishment of a protein production system using silkworms by Kyushu University ▽ University of Tsukuba measures the state of swallowing food only by sound and standardizes swallowing ability measurement ▽ University of Tsukuba improves reproductive function of livestock using tomorrow's leaf active ingredient ▽ University of Tokyo develops preventive and therapeutic agents for norovirus infection ▽ Tokyo Institute of Technology develops plasma endoscopic treatment device using multi-gas temperature controlled plasma ▽ Development of medical equipment and drug discovery support tools utilizing the shape processing technology of high-density collagen fibers by the Institute of Agricultural and Biological Resources.This program utilizes human resources with commercialization know-how such as venture capital as business promoters, and aims to create venture companies while building business strategies and intellectual property strategies with researchers.
From April to July 2015, 4 applications were received from universities and research institutes, and 7 themes that had been continued in the 115st and 1nd cycle examinations were scrutinized, and 2 were made into new projects. I chose.
